MedPath

Sealing of the pouch attached with left upper chamber of heart during routine cardiac surgery for prevention of brain attack and other diseases caused by blood clots going to other orgnas.

Phase 2
Conditions
Health Condition 1: null- having Atrial Fibrillation Undergoing a clinically indicated cardiac surgical procedure with the use of cardiopulmonary bypass
Registration Number
CTRI/2018/02/011925
Lead Sponsor
Population Health Research Institute
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1) Age >= 18 years of age

2) Undergoing a clinically indicated cardiac surgical procedure with the use of cardiopulmonary bypass

3) A documented history of atrial fibrillation or atrial flutter

4) CHA2DS2-VASc score >= 2

5) Written informed consent

Exclusion Criteria

1) Patients undergoing any of the following procedures:

a. Off-pump cardiac surgery

b. Heart transplant

c. Complex congenital heart surgery

d. Sole indication for surgery is ventricular assist device insertion

e. Previous cardiac surgery requiring opening of the pericardium

f. Mechanical valve implantation

2) Patients who have had a previous placement of a percutaneous LAA closure device

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Stroke or systemic arterial embolism <br/ ><br>First occurrence of ischemic stroke or transient ischemic attack with positive neuroimaging or systemic arterial embolismTimepoint: Over the duration of follow-up (five years)
Secondary Outcome Measures
NameTimeMethod
All cause deathTimepoint: median follow-up of 4 years;All cause stroke or transient ischemic attack with positive neuroimaging or systemic arterial embolismTimepoint: median follow-up of 4 years;Ischemic stroke or transient ischemic attack with positive neuroimaging or systemic arterial embolism 30 days after surgeryTimepoint: Common termination point (median follow-up of 4 years);Ischemic stroke or transient ischemic attack with positive neuroimaging or systemic arterial embolism or deathTimepoint: Common termination point (median follow-up of 4 years)
© Copyright 2025. All Rights Reserved by MedPath